A new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging lays the foundation for treating addiction with transcranial magnetic stimulation
In a study investigating the use of transcranial magnetic stimulation (TMS) for drug addiction, researchers at Medical University of South Carolina are the first to demonstrate that the noninvasive brain stimulation technique can dampen brain activity in response to drug cues in chronic alcohol users and chronic cocaine users. The findings are published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Although the last 50 years of clinical and preclinical research have demonstrated that addiction is a brain disease, there are still no neural circuit-based treatments for substance dependence or the brain functions involved in the disorder. “Here, for the first time, we demonstrate that a new non-invasive brain stimulation technique may be the first tool available to fill this critical void in addiction treatment development,” said senior author Colleen Hanlon, PhD.
Elevated brain activity in response to drug cues—referred to as cue reactivity—occurs with many types of drugs, including nicotine, alcohol, marijuana, and cocaine. Cue reactivity also predicts relapse in addiction, so treatment approaches targeting the neural circuitry related to cue reactivity may directly impact cue-induced relapse in patients.
“Therefore, these results have a tremendous potential to impact both basic discovery neuroscience as well as targeted clinical treatment development for substance dependence,” said Dr. Hanlon.
First author of the paper Tonisha Kearney-Ramos, PhD, and colleagues performed two independent studies at the same time, one involving 25 people with cocaine use disorder and the other involving 24 people with alcohol use disorder. The participants received one session of TMS, which targeted magnetic stimulation to circuitry critical for drug-taking behaviors—the ventromedial prefrontal cortex. The real stimulation session was compared against a sham session that mimicked the experience of receiving TMS without actual brain stimulation.
Brain imaging before and after TMS revealed that when alcohol users viewed images of alcohol-related cues, such as a liquor bottle, the single TMS session significantly reduced their drug cue reactivity. The same was true for cocaine users when viewing images of cocaine-related cues.
“Since cue reactivity has previously been associated with abstinence, these studies suggest a common mechanism for treatment effects across disorders, with fMRI serving as a promising neural readout of treatment effects,” said Cameron Carter, MD, Editor of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
However, it is still unclear if the changes in brain activity observed in the study will translate to reduced drug or alcohol use. The participants did not report any changes in their drug or alcohol craving after TMS. The authors think that repeated sessions of the targeted stimulation may be needed to see changes in self-reported craving. The researchers hope to answer this question in an ongoing clinical trial involving multiple TMS sessions in cocaine users.
In addition to substance abuse, elevated cue-reactivity is a core symptom of many diseases, such as post-traumatic stress disorder, generalized anxiety disorder, traumatic brain injury, smoking, and obesity, said Dr. Hanlon. “Therefore, the treatment described in this manuscript may have implications far beyond the substance abuse field.”
The Latest on: Transcranial magnetic stimulation
via Google News
The Latest on: Transcranial magnetic stimulation
- Transcranial Magnetic Stimulators Market Is Predicted to Rise; Product Launches by Key Players Will Foster Growth, says Fortune Business Insightson March 4, 2021 at 5:40 pm
Shifting focus towards the treatment of rare diseases is a factor driving the global transcranial magnetic stimulators market size says Fortune Business insights in a report, titled “Transcranial ...
- NeuroStar® Advanced Therapy Outcomes Registry Clinical Data Published in Brain Stimulation Validates Depression Treatment Protocolson February 23, 2021 at 5:10 am
(NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric ...
- NeuroStar® Advanced Therapy Outcomes Registry Clinical Data Published in Brain Stimulation ...on February 23, 2021 at 5:02 am
The NeuroStar Outcomes Registry launched in November 2016 for the purpose of collecting and analyzing outcomes data from treatment in real-world clinical settings with Neuronetics’ NeuroStar Advanced ...
- Mercy Health reveals new electrical pulse therapy for depressionon February 22, 2021 at 6:45 pm
Mercy Health announced Monday a new tool they are using to battle severe depression for patients. The Youngstown Behavioral Health team is now using Transcranial Magnetic Stimulation (TMS). TMS is a ...
- Omaha Psychiatrist uses magnetic fields to treat depressionon February 21, 2021 at 8:34 pm
An Omaha psychiatrist is seeing improvement in patients with difficult to treat depression by using a therapy called Transcranial Magnetic Stimulation, or TMS. The treatment has had FDA clearance for ...
- 'Where did I park my car?' Brain stimulation improves mental time travelon February 20, 2021 at 2:42 pm
In a new study, scientists improved memory of complex, realistic events by applying transcranial magnetic stimulation (TMS) to the brain network responsible for memory. The researchers then had ...
- rTMS Therapy and the dangers of flawed guideline development. An open letter to the RANZCPon February 15, 2021 at 4:00 pm
I have seen resistance to the development and uptake of repetitive Transcranial Magnetic Stimulation (rTMS) treatment in the Australian psychiatric community but truly felt we past this with the ...
- Causal modulation of right hemisphere fronto-parietal phase synchrony with Transcranial Magnetic Stimulation during a conscious visual detection taskon February 15, 2021 at 2:53 am
Our work supports future applications of non-invasive brain stimulation to restore impaired visually-guided behaviors by operating on top-down attentional modulatory mechanisms.
- Transcranial Magnetic Stimulators Market 2021, Size, Share, Revenue, Growth, Trends, Competitive Landscape, Forecast Report 2021-2028on February 11, 2021 at 1:01 am
Launch of Cobot - An Innovative Robot for Transcranial Magnetic Stimulation to Boost Market Axium Robotics, a company based in Strasbourg, France, launched its TMS-Cobot TS MV, after receiving ...
via Bing News